交易 Adaptive Biotechnologies Corporation - ADPT CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.04 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Adaptive Biotechnologies Corp ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 27, 2024 | 2.87 | -0.05 | -1.71% | 2.92 | 2.92 | 2.73 |
Mar 26, 2024 | 2.85 | -0.21 | -6.86% | 3.06 | 3.17 | 2.83 |
Mar 25, 2024 | 3.09 | -0.07 | -2.22% | 3.16 | 3.26 | 3.07 |
Mar 22, 2024 | 3.22 | -0.03 | -0.92% | 3.25 | 3.27 | 3.13 |
Mar 21, 2024 | 3.31 | -0.04 | -1.19% | 3.35 | 3.50 | 3.29 |
Mar 20, 2024 | 3.36 | 0.15 | 4.67% | 3.21 | 3.40 | 3.13 |
Mar 19, 2024 | 3.26 | 0.15 | 4.82% | 3.11 | 3.32 | 3.09 |
Mar 18, 2024 | 3.16 | -0.07 | -2.17% | 3.23 | 3.24 | 3.09 |
Mar 15, 2024 | 3.21 | 0.00 | 0.00% | 3.21 | 3.31 | 3.20 |
Mar 14, 2024 | 3.25 | -0.05 | -1.52% | 3.30 | 3.35 | 3.18 |
Mar 13, 2024 | 3.39 | -0.11 | -3.14% | 3.50 | 3.59 | 3.33 |
Mar 12, 2024 | 3.57 | -0.17 | -4.55% | 3.74 | 3.77 | 3.55 |
Mar 11, 2024 | 3.77 | 0.20 | 5.60% | 3.57 | 3.92 | 3.53 |
Mar 8, 2024 | 3.63 | 0.20 | 5.83% | 3.43 | 3.72 | 3.43 |
Mar 7, 2024 | 3.43 | -0.12 | -3.38% | 3.55 | 3.74 | 3.42 |
Mar 6, 2024 | 3.60 | -0.19 | -5.01% | 3.79 | 3.85 | 3.50 |
Mar 5, 2024 | 3.75 | 0.38 | 11.28% | 3.37 | 3.77 | 3.35 |
Mar 4, 2024 | 3.97 | -0.03 | -0.75% | 4.00 | 4.04 | 3.74 |
Mar 1, 2024 | 4.00 | -0.03 | -0.74% | 4.03 | 4.22 | 3.96 |
Feb 29, 2024 | 4.10 | -0.05 | -1.20% | 4.15 | 4.31 | 4.09 |
Adaptive Biotechnologies Corporation Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Tuesday, April 2, 2024 | ||
時間 (UTC) 20:30 | 國家 US
| 事件 Adaptive Biotechnologies Corp to Hold a Business Update Conference Call Adaptive Biotechnologies Corp to Hold a Business Update Conference CallForecast(預報) -返回 - |
Wednesday, May 1, 2024 | ||
時間 (UTC) 20:00 | 國家 US
| 事件 Q1 2024 Adaptive Biotechnologies Corp Earnings Release Q1 2024 Adaptive Biotechnologies Corp Earnings ReleaseForecast(預報) -返回 - |
Friday, June 7, 2024 | ||
時間 (UTC) 16:00 | 國家 US
| 事件 Adaptive Biotechnologies Corp Annual Shareholders Meeting Adaptive Biotechnologies Corp Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 185.308 | 154.344 | 98.382 | 85.071 | 55.663 |
收入 | 185.308 | 154.344 | 98.382 | 85.071 | 55.663 |
收入成本,共計 | 57.909 | 49.301 | 22.53 | 22.274 | 19.668 |
毛利 | 127.399 | 105.043 | 75.852 | 62.797 | 35.995 |
總營業費用 | 385.494 | 363.31 | 251.199 | 163.462 | 105.419 |
銷售/一般/行政費用,總計 | 183.23 | 169.967 | 110.894 | 68.785 | 44.895 |
研究與開發 | 122.717 | 142.343 | 116.072 | 70.705 | 39.157 |
Depreciation / Amortization | 20.038 | 1.699 | 1.703 | 1.698 | 1.699 |
異常費用(收入) | 1.6 | 0 | 0 | ||
營業收入 | -200.186 | -208.966 | -152.817 | -78.391 | -49.756 |
利息收入(費用),非經營淨值 | -0.182 | 1.668 | 6.59 | 9.785 | 3.309 |
稅前淨收入 | -200.368 | -207.298 | -146.227 | -68.606 | -46.447 |
稅後淨收入 | -200.368 | -207.298 | -146.227 | -68.606 | -46.447 |
未計算非常項目前的淨收益 | -200.191 | -207.279 | -146.227 | -68.606 | -46.447 |
淨收入 | -200.191 | -207.279 | -146.227 | -68.606 | -46.447 |
Total Adjustments to Net Income | 0 | 0 | -0.964 | 0.102 | |
普通股股東可獲收益 (不含非經常性項目) | -200.191 | -207.279 | -146.227 | -69.57 | -46.345 |
普通股股東可獲收益 (含非經常性項目) | -200.191 | -207.279 | -146.227 | -69.57 | -46.345 |
攤薄淨收入 | -200.191 | -207.279 | -146.227 | -69.57 | -46.345 |
攤薄後加權平均股 | 142.516 | 140.355 | 131.216 | 125.238 | 118.474 |
扣除特別項目的每股攤薄盈利 | -1.40469 | -1.47682 | -1.1144 | -0.5555 | -0.39118 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
每股正常攤薄盈利 | -1.3905 | -1.47682 | -1.1144 | -0.5555 | -0.39118 |
非常規項目總計 | 0 | ||||
少數股東權益 | 0.177 | 0.019 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 48.926 | 37.647 | 55.198 | 47.83 | 43.66 |
收入 | 48.926 | 37.647 | 55.198 | 47.83 | 43.66 |
收入成本,共計 | 17.91 | 18.681 | 16.589 | 14.907 | 13.221 |
毛利 | 31.016 | 18.966 | 38.609 | 32.923 | 30.439 |
總營業費用 | 96.744 | 94.84 | 94.384 | 93.261 | 96.162 |
銷售/一般/行政費用,總計 | 46.174 | 43.139 | 46.144 | 42.268 | 45.481 |
研究與開發 | 29.471 | 28.828 | 27.341 | 30.017 | 32.76 |
Depreciation / Amortization | 3.189 | 4.192 | 4.31 | 6.069 | 4.7 |
營業收入 | -47.818 | -57.193 | -39.186 | -45.431 | -52.502 |
利息收入(費用),非經營淨值 | 0.007 | -0.507 | -0.983 | 0.112 | 0.418 |
稅前淨收入 | -47.811 | -57.7 | -40.169 | -45.319 | -52.084 |
稅後淨收入 | -47.811 | -57.7 | -40.169 | -45.319 | -52.084 |
未計算非常項目前的淨收益 | -47.81 | -57.699 | -40.128 | -45.281 | -52.046 |
淨收入 | -47.81 | -57.699 | -40.128 | -45.281 | -52.046 |
普通股股東可獲收益 (不含非經常性項目) | -47.81 | -57.699 | -40.128 | -45.281 | -52.046 |
普通股股東可獲收益 (含非經常性項目) | -47.81 | -57.699 | -40.128 | -45.281 | -52.046 |
攤薄淨收入 | -47.81 | -57.699 | -40.128 | -45.281 | -52.046 |
攤薄後加權平均股 | 144.398 | 143.511 | 143.061 | 142.929 | 142.364 |
扣除特別項目的每股攤薄盈利 | -0.3311 | -0.40205 | -0.2805 | -0.31681 | -0.36559 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.3311 | -0.40205 | -0.2805 | -0.31681 | -0.36559 |
少數股東權益 | 0.001 | 0.001 | 0.041 | 0.038 | 0.038 |
異常費用(收入) | 0 | 0 | 0 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 562.146 | 402.748 | 726.914 | 612.69 | 180.718 |
現金和短期投資 | 498.196 | 353.061 | 688.269 | 576.866 | 165.018 |
現金等價物 | 90.03 | 139.065 | 123.436 | 96.576 | 55.03 |
短期投資 | 408.166 | 213.996 | 564.833 | 480.29 | 109.988 |
應收賬款總額,淨額 | 40.057 | 17.409 | 10.047 | 12.676 | 4.807 |
應收賬款 - 貿易,淨額 | 40.057 | 17.409 | 10.047 | 12.676 | 4.807 |
總庫存 | 14.453 | 19.263 | 14.063 | 9.069 | 7.838 |
預付的費用 | 9.44 | 13.015 | 14.535 | 14.079 | 3.055 |
總資産 | 856.617 | 923.344 | 1116.41 | 912.302 | 332.688 |
物業/廠房/設備,總計 - 淨額 | 164.21 | 172.94 | 139.042 | 60.355 | 19.125 |
物業/廠房/設備,總計 - 總額 | 218.56 | 209.166 | 163.424 | 78.471 | 31.577 |
累計折舊,總計 | -54.35 | -36.226 | -24.382 | -18.116 | -12.452 |
商譽,淨額 | 118.972 | 118.972 | 118.972 | 118.972 | 118.972 |
無形資産,淨額 | 6.827 | 8.526 | 10.225 | 11.928 | 13.626 |
長期投資 | 0 | 217.145 | 118.525 | 105.435 | 0 |
其他長期資産,總計 | 4.462 | 3.013 | 2.736 | 2.922 | 0.247 |
流動負債總額 | 109.788 | 113.807 | 105.197 | 78.313 | 22.8 |
應付賬款 | 8.084 | 3.307 | 3.237 | 4.453 | 1.793 |
預提費用 | 37.395 | 29.649 | 26.874 | 10.433 | 7.203 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 64.309 | 80.851 | 75.086 | 63.427 | 13.804 |
負債總額 | 392.452 | 319.352 | 373.148 | 341.263 | 29.942 |
長期債務總額 | 0 | 0 | 0 | 36.607 | 0.336 |
長期債務 | 0 | 0.336 | |||
其他負債,總計 | 282.731 | 205.435 | 267.951 | 226.343 | 6.806 |
股權 | 464.165 | 603.992 | 743.266 | 571.039 | 302.746 |
Redeemable Preferred Stock | 0 | 572.866 | |||
Preferred Stock - Non Redeemable, Net | -12.008 | ||||
普通股 | 0.014 | 0.014 | 0.014 | 0.012 | 0.001 |
額外實收資本 | 1387.35 | 1324.01 | 1253.97 | 935.834 | 37.902 |
留存收益(累計赤字) | -919.082 | -718.891 | -511.612 | -365.478 | -295.908 |
其他權益,總計 | -4.116 | -1.137 | 0.893 | 0.671 | -0.107 |
總負債和股東權益 | 856.617 | 923.344 | 1116.41 | 912.302 | 332.688 |
已發行普通股總數 | 143.105 | 141.394 | 137.647 | 125.238 | 118.474 |
資本租賃義務 | 0 | 36.607 | |||
少數股權 | -0.067 | 0.11 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 435.237 | 476.809 | 501.333 | 562.146 | 564.38 |
現金和短期投資 | 371.132 | 417.23 | 440.695 | 498.196 | 508.079 |
現金等價物 | 88.713 | 109.24 | 94.612 | 90.03 | 217.552 |
短期投資 | 282.419 | 307.99 | 346.083 | 408.166 | 290.527 |
應收賬款總額,淨額 | 31.211 | 31.545 | 30.972 | 40.057 | 26.549 |
應收賬款 - 貿易,淨額 | 31.211 | 31.545 | 30.972 | 40.057 | 26.549 |
總庫存 | 19.49 | 18.96 | 19.874 | 14.453 | 17.345 |
預付的費用 | 13.404 | 9.074 | 9.792 | 9.44 | 12.407 |
總資産 | 717.682 | 764.54 | 791.463 | 856.617 | 884.208 |
物業/廠房/設備,總計 - 淨額 | 152.012 | 156.499 | 160.254 | 164.21 | 169.267 |
商譽,淨額 | 118.972 | 118.972 | 118.972 | 118.972 | 118.972 |
無形資産,淨額 | 5.557 | 5.985 | 6.408 | 6.827 | 7.256 |
長期投資 | 0 | 19.698 | |||
其他長期資産,總計 | 5.904 | 6.275 | 4.496 | 4.462 | 4.635 |
流動負債總額 | 93.298 | 95.335 | 90.101 | 109.788 | 104.018 |
應付賬款 | 4.483 | 9.163 | 6.333 | 8.084 | 4.163 |
預提費用 | 33.475 | 28.255 | 23.448 | 37.589 | 31.963 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 55.34 | 57.917 | 60.32 | 64.115 | 67.892 |
負債總額 | 355.95 | 368.504 | 367.443 | 392.452 | 396.368 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
少數股權 | -0.095 | -0.069 | -0.068 | -0.067 | -0.026 |
其他負債,總計 | 262.747 | 273.238 | 277.41 | 282.731 | 292.376 |
股權 | 361.732 | 396.036 | 424.02 | 464.165 | 487.84 |
普通股 | 0.014 | 0.014 | 0.014 | 0.014 | 0.014 |
額外實收資本 | 1436.86 | 1421.51 | 1402.69 | 1387.35 | 1372.75 |
留存收益(累計赤字) | -1074.89 | -1024.59 | -976.781 | -919.082 | -878.954 |
其他權益,總計 | -0.25 | -0.893 | -1.905 | -4.116 | -5.971 |
總負債和股東權益 | 717.682 | 764.54 | 791.463 | 856.617 | 884.208 |
已發行普通股總數 | 144.773 | 144.645 | 144.28 | 143.105 | 142.987 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -200.368 | -207.298 | -146.227 | -68.606 | -46.447 |
經營活動産生的現金 | -183.945 | -192.727 | -149.683 | 205.404 | -32.259 |
經營活動産生的現金 | 19.221 | 12.254 | 6.769 | 6.093 | 4.301 |
Amortization | 1.699 | 1.699 | 1.703 | 1.698 | 1.699 |
非現金物品 | 67.049 | 57.434 | 28.871 | 11.286 | 9.911 |
營運資金的變化 | -71.546 | -56.816 | -40.799 | 254.933 | -1.723 |
投資活動産生的現金 | 2.905 | 181.21 | -117.044 | -481.697 | 0.736 |
資本支出 | -16.349 | -61.746 | -18.803 | -11.2 | -6.318 |
其他投資現金流量項目,總計 | 19.254 | 242.956 | -98.241 | -470.497 | 7.054 |
融資活動産生的現金 | 132.265 | 27.146 | 293.587 | 319.916 | 1.248 |
融資現金流項目 | 124.375 | 0.429 | -0.321 | -4.989 | -0.02 |
股票的發行(報廢),淨額 | 7.89 | 26.717 | 293.908 | 324.905 | 1.268 |
現金淨變化 | -48.775 | 15.629 | 26.86 | 43.623 | -30.275 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -57.7 | -200.368 | -160.199 | -114.88 | -62.796 |
Cash From Operating Activities | -59.152 | -183.945 | -153.926 | -111.518 | -64.453 |
Cash From Operating Activities | 5.004 | 19.221 | 14.364 | 9.409 | 4.637 |
Amortization | 0.419 | 1.699 | 1.27 | 0.842 | 0.419 |
Non-Cash Items | 17.6 | 67.049 | 51.049 | 34.802 | 15.495 |
Changes in Working Capital | -24.475 | -71.546 | -60.41 | -41.691 | -22.208 |
Cash From Investing Activities | 62.979 | 2.905 | 100.449 | 42.434 | 37.688 |
Capital Expenditures | -2.924 | -16.349 | -13.807 | -8.375 | -3.077 |
Other Investing Cash Flow Items, Total | 65.903 | 19.254 | 114.256 | 50.809 | 40.765 |
Cash From Financing Activities | 0.672 | 132.265 | 132.259 | 6.739 | 2.749 |
Financing Cash Flow Items | 124.375 | 124.691 | 0 | 0 | |
Issuance (Retirement) of Stock, Net | 0.672 | 7.89 | 7.568 | 6.739 | 2.749 |
Net Change in Cash | 4.499 | -48.775 | 78.782 | -62.345 | -24.016 |
Cash Interest Paid | 2.76 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Diagnostics & Testing |
1165 Eastlake Ave E
SEATTLE
WASHINGTON 98109
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易